Toripalimab-Induced Dermatomyositis in a Patient with Metastatic Melanoma

Abstract Toripalimab is a monoclonal antibody targeting programmed cell death protein 1 (PD-1). It has recently been approved as an immune checkpoint inhibitor in second-line therapies in patients with unresectable or metastatic melanoma; however, it may be associated with various immune-related adv...

Full description

Saved in:
Bibliographic Details
Main Authors: Jingrong Lin (Author), Minmin Xue (Author), Mingyang Gao (Author), Pu Yu (Author), Shixin Han (Author)
Format: Book
Published: Adis, Springer Healthcare, 2020-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available